Swiss National Bank
ODT

Swiss National Bank’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Swiss National Bank’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-44,000
Closed -$150K – 2658
2021
Q1 		$150K Buy
44,000
+2,000
+5% +$37.8K ﹤0.01% 2479
2020
Q4 		$806K Hold
42,000
– – ﹤0.01% 2380
2020
Q3 		$564K Buy
42,000
+13,400
+47% +$380K ﹤0.01% 2339
2020
Q2 		$1.21M Buy
28,600
+900
+3% +$29.1K ﹤0.01% 1995
2020
Q1 		$765K Hold
27,700
– – ﹤0.01% 1978
2019
Q4 		$899K Buy
27,700
+1,100
+4% +$34.1K ﹤0.01% 2200
2019
Q3 		$692K Buy
26,600
+14,200
+115% +$475K ﹤0.01% 2238
2019
Q2 		$455K Buy
+12,400
New +$297K ﹤0.01% 2440

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Swiss National Bank's ODT Position: Q2 2021 in Review

Swiss National Bank sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q2 2021, closing a stake of 44,000 shares — an estimated $150K sold.

Swiss National Bank first reported a position in ODT in Q2 2019 and held it in 8 quarters. The position peaked at $1.21M in Q2 2020. 69 funds tracked by Wall St. Rank hold ODT as of Q2 2021.

  • Swiss National Bank reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Swiss National Bank sold 44,000 Odonate Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $150K.
  • Swiss National Bank first reported a position in Odonate Therapeutics, Inc. Common Stock in Q2 2019 and held it in 8 quarters.
  • Swiss National Bank's Odonate Therapeutics, Inc. Common Stock position peaked at $1.21M in Q2 2020.
  • 69 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Swiss National Bank's 13F filing for Q2 2021, filed 6 Aug 2021.